Apoptosis characterization in mononuclear blood leukocytes of HIV patients during dengue acute disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 04 2020
Historique:
received: 02 09 2019
accepted: 18 03 2020
entrez: 15 4 2020
pubmed: 15 4 2020
medline: 1 12 2020
Statut: epublish

Résumé

Dengue virus (DENV) co-circulation in Brazil represents a challenge for treatment and vaccine development. Despite public health impact, the occurrence of coinfections with other viruses is a common event. Increased T cell activation and altered inflammatory response are found during DENV coinfection with Human Immunodeficiency Virus (HIV) impacting HIV-pathogenesis. Even with Antiretroviral therapy (ART), HIV- treated patients had chronic immune activation and lymphocyte apoptosis. However, apoptotic mechanisms have not been investigated during coinfection with DENV. Our attention was attracted to apoptotic cell markers expressions in PBMCs from DENV and DENV/HIV coinfected patients. We found CD4/CD8 ratio inversion in most coinfected patients. CD4 T and CD8 T-cell subsets from DENV and DENV/HIV groups expressed low levels of anti-apoptotic protein Bcl-2. Furthermore, CD8 CD95 double positive cells frequency expressing low levels of Bcl-2 were significantly higher in these patients. Additionally, the density of Bcl-2 on classical monocytes (CD14

Identifiants

pubmed: 32286360
doi: 10.1038/s41598-020-62776-4
pii: 10.1038/s41598-020-62776-4
pmc: PMC7156518
doi:

Substances chimiques

BCL2 protein, human 0
Proto-Oncogene Proteins c-bcl-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6351

Références

WHO/TDR. Dengue: guidelines for diagnosis, treatment, prevention and control–New edition. World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR), http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf . (2009).
Freed, E. O. HIV-1 and the host cell: an intimate association. Trends Microbiol 12, 170–177 (2004).
pubmed: 15051067 doi: 10.1016/j.tim.2004.02.001 pmcid: 15051067
Nagata, S. & Tanaka, M. Programmed cell death and the immune system. Nat Rev Immunol 17, 333–340 (2017).
pubmed: 28163302 doi: 10.1038/nri.2016.153 pmcid: 28163302
Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9, 47–59 (2008).
pubmed: 18097445 doi: 10.1038/nrm2308 pmcid: 18097445
Yatim, N. & Albert, M. L. Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity. Immunity 35, 478–490 (2011).
pubmed: 22035840 doi: 10.1016/j.immuni.2011.10.010 pmcid: 22035840
Simonelli, C. et al. Prognostic factors in human herpesvirus 8-related lymphoproliferative disorders associated with HIV infection. J Clin Oncol 24, 209; author reply 209–210 (2006).
Azeredo, E. L. et al. Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease. Mem Inst Oswaldo Cruz 101, 437–449 (2006).
pubmed: 16951817 doi: 10.1590/S0074-02762006000400016 pmcid: 16951817
Green, S. et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 180, 1429–1435 (1999).
pubmed: 10515800 doi: 10.1086/315072 pmcid: 10515800
de-Oliveira-Pinto, L. M. et al. Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever. PLoS One 7, e38527 (2012).
pubmed: 22815692 pmcid: 3398008 doi: 10.1371/journal.pone.0038527
Limonta, D., Capo, V., Torres, G., Perez, A. B. & Guzman, M. G. Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol 40, 50–54 (2007).
pubmed: 17693133 doi: 10.1016/j.jcv.2007.04.024 pmcid: 17693133
Castillo, J. A. & Urcuqui-Inchima, S. Mechanisms of monocyte cell death triggered by dengue virus infection. Apoptosis 23, 576–586 (2018).
pubmed: 30267240 doi: 10.1007/s10495-018-1488-1 pmcid: 30267240
Torrentes-Carvalho, A. et al. Dengue-2 infection and the induction of apoptosis in human primary monocytes. Mem Inst Oswaldo Cruz 104, 1091–1099 (2009).
pubmed: 20140369 doi: 10.1590/S0074-02762009000800005 pmcid: 20140369
Torrentes-Carvalho, A. et al. Regulation of T lymphocyte apoptotic markers is associated to cell activation during the acute phase of dengue. Immunobiology 219, 329–340 (2014).
pubmed: 24508270 doi: 10.1016/j.imbio.2013.11.002 pmcid: 24508270
Torrentes-Carvalho, A. et al. Characterization of clinical and immunological features in patients coinfected with dengue virus and HIV. Clin Immunol 164, 95–105 (2016).
pubmed: 26826597 doi: 10.1016/j.clim.2016.01.005 pmcid: 26826597
Lanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J. & Vorndam, A. V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30, 545–551 (1992).
pubmed: 1372617 pmcid: 265106 doi: 10.1128/JCM.30.3.545-551.1992
Warnes, G. R. et al. Various R Programming Tools for Plotting Data. R Package Version 2.17. 0. Pittsford, NY: Computer software. [Google Scholar] (2015).
Team, R. C. A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing;. [Google Scholar] (2018).
Ryota Suzuki, Y. T. A. H. S. Hierarchical Clustering with P-Values via Multiscale Bootstrap Resampling. R package version 2.2-0, https://CRAN.R-project.org/package=pvclust (2019).
Jari Oksanen, F. G. B. et al. Community Ecology Package. R package version 2.5-6, https://CRAN.R-project.org/package=vegan (2019).
Boudet, F., Lecoeur, H. & Gougeon, M. L. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J Immunol 156, 2282–2293 (1996).
pubmed: 8690919 pmcid: 8690919
Ziegler-Heitbrock, L. Blood Monocytes and Their Subsets: Established Features and Open Questions. Front Immunol 6, 423 (2015).
pubmed: 26347746 pmcid: 4538304 doi: 10.3389/fimmu.2015.00423
Castillo, J. A., Naranjo, J. S., Rojas, M., Castano, D. & Velilla, P. A. Role of Monocytes in the Pathogenesis of Dengue. Arch Immunol Ther Exp (Warsz) 67, 27–40 (2019).
doi: 10.1007/s00005-018-0525-7
Redza-Dutordoir, M. & Averill-Bates, D. A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 1863, 2977–2992 (2016).
pubmed: 27646922 doi: 10.1016/j.bbamcr.2016.09.012 pmcid: 27646922
Sepasi Tehrani, H. & Moosavi-Movahedi, A. A. Catalase and its mysteries. Prog Biophys Mol Biol 140, 5–12 (2018).
pubmed: 29530789 doi: 10.1016/j.pbiomolbio.2018.03.001 pmcid: 29530789
Donalisio, M. R., Freitas, A. R. R. & Zuben, A. Arboviruses emerging in Brazil: challenges for clinic and implications for public health. Rev Saude Publica 51, 30 (2017).
pubmed: 28423140 pmcid: 5396504 doi: 10.1590/s1518-8787.2017051006889
Hottz, E. D. et al. Platelet function in HIV plus dengue coinfection associates with reduced inflammation and milder dengue illness. Sci Rep 9, 7096 (2019).
pubmed: 31068600 pmcid: 6506591 doi: 10.1038/s41598-019-43275-7
Pang, J., Thein, T. L., Lye, D. C. & Leo, Y. S. Differential clinical outcome of dengue infection among patients with and without HIV infection: a matched case-control study. Am J Trop Med Hyg 92, 1156–1162 (2015).
pubmed: 25825389 pmcid: 4458819 doi: 10.4269/ajtmh.15-0031
Azeredo, E. L. et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 204, 494–507 (2001).
pubmed: 11776403 doi: 10.1078/0171-2985-00058 pmcid: 11776403
Pereira, M. F., Luz, E., Netto, E. M., Barbosa, M. H. F. & Brites, C. Low variation in initial CD4 cell count in a HIV referral center, in Salvador, Brazil, from 2002 to 2015. Braz J Infect Dis 22, 245–247 (2018).
pubmed: 29883585 doi: 10.1016/j.bjid.2018.05.005 pmcid: 29883585
Khoury, Z., Silva, R. S. & Villela, W. Factors associated with a delay in seeking HIV/AIDS treatment in Sao Paulo, Brazil. AIDS Behav 19, 679–683 (2015).
pubmed: 25210003 doi: 10.1007/s10461-014-0885-x pmcid: 25210003
Souza, P. R. Jr., Szwarcwald, C. L. & Castilho, E. A. Delay in introducing antiretroviral therapy in patients infected by HIV in Brazil, 2003–2006. Clinics (Sao Paulo) 62, 579–584 (2007).
doi: 10.1590/S1807-59322007000500008
Serrano-Villar, S. et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 10, e1004078 (2014).
pubmed: 24831517 pmcid: 4022662 doi: 10.1371/journal.ppat.1004078
Bruno, G., Saracino, A., Monno, L. & Angarano, G. The Revival of an “Old” Marker: CD4/CD8 Ratio. AIDS Rev 19, 81–88 (2017).
pubmed: 28182620 pmcid: 28182620
Mongkolsapaya, J. et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? Journal of immunology 176, 3821–3829 (2006).
doi: 10.4049/jimmunol.176.6.3821
Limonta, D. et al. Apoptotic mediators in patients with severe and non-severe dengue from Brazil. J Med Virol 86, 1437–1447 (2014).
pubmed: 24170344 doi: 10.1002/jmv.23832 pmcid: 24170344
Limjindaporn, T. et al. Sensitization to Fas-mediated apoptosis by dengue virus capsid protein. Biochemical and biophysical research communications 362, 334–339 (2007).
pubmed: 17707345 doi: 10.1016/j.bbrc.2007.07.194 pmcid: 17707345
Mongkolsapaya, J. et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9, 921–927 (2003).
pubmed: 12808447 doi: 10.1038/nm887 pmcid: 12808447
Tillmann, H. L. et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345, 715–724 (2001).
pubmed: 11547740 doi: 10.1056/NEJMoa010398 pmcid: 11547740
Moenkemeyer, M., Schmidt, R. E., Wedemeyer, H., Tillmann, H. L. & Heiken, H. GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients. J Med Virol 80, 1933–1940 (2008).
pubmed: 18814245 doi: 10.1002/jmv.21305 pmcid: 18814245
Wong, M. E., Jaworowski, A. & Hearps, A. C. The HIV Reservoir in Monocytes and Macrophages. Front Immunol 10, 1435 (2019).
pubmed: 31297114 pmcid: 6607932 doi: 10.3389/fimmu.2019.01435
Kwissa, M. et al. Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe 16, 115–127 (2014).
pubmed: 24981333 pmcid: 4116428 doi: 10.1016/j.chom.2014.06.001
Azeredo, E. L. et al. Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology 130, 202–216 (2010).
pubmed: 20113369 pmcid: 2878465 doi: 10.1111/j.1365-2567.2009.03224.x
Younas, M., Psomas, C., Reynes, J. & Corbeau, P. Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy. HIV Med 17, 89–105 (2016).
pubmed: 26452565 doi: 10.1111/hiv.12310 pmcid: 26452565
Chen, P. et al. Perturbations of Monocyte Subsets and Their Association with T Helper Cell Differentiation in Acute and Chronic HIV-1-Infected Patients. Front Immunol 8, 272 (2017).
pubmed: 28348563 pmcid: 5347116
Arias, J. et al. Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue. Virology 452–453, 42–51 (2014).
pubmed: 24606681 doi: 10.1016/j.virol.2013.12.027 pmcid: 24606681
Suzuki, T. et al. Infection with flaviviruses requires BCLXL for cell survival. PLoS Pathog 14, e1007299 (2018).
pubmed: 30261081 pmcid: 6177207 doi: 10.1371/journal.ppat.1007299
Matsuda, T. et al. Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. J Gen Virol 86, 1055–1065 (2005).
pubmed: 15784899 pmcid: 2917180 doi: 10.1099/vir.0.80531-0
Liao, H., Xu, J. & Huang, J. FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells. J Med Virol 82, 1392–1399 (2010).
pubmed: 20572077 doi: 10.1002/jmv.21815 pmcid: 20572077
Cummins, N. W. & Badley, A. D. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis 1, e99 (2010).
pubmed: 21368875 pmcid: 3032328 doi: 10.1038/cddis.2010.77
Massanella, M. et al. Assessing main death pathways in T lymphocytes from HIV infected individuals. Cytometry A 83, 648–658 (2013).
pubmed: 23650261 doi: 10.1002/cyto.a.22299 pmcid: 23650261
Rizza, S. A. & Badley, A. D. HIV protease inhibitors impact on apoptosis. Med Chem 4, 75–79, https://doi.org/10.2174/157340608783331443 (2008).
doi: 10.2174/157340608783331443 pubmed: 18220972 pmcid: 3149800
Badley, A. D. et al. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest 102, 79–87 (1998).
pubmed: 9649560 pmcid: 509068 doi: 10.1172/JCI2691
Badley, A. D. et al. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ 6, 420–432, https://doi.org/10.1038/sj.cdd.4400509 (1999).
doi: 10.1038/sj.cdd.4400509 pubmed: 10381636 pmcid: 10381636
Ehrhard, S. et al. Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals. Infection 36, 120–129 (2008).
pubmed: 18379725 doi: 10.1007/s15010-008-7368-9 pmcid: 18379725
Sevilya, Z. et al. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef. Front Immunol 9, 2068 (2018).
pubmed: 30254642 pmcid: 6141733 doi: 10.3389/fimmu.2018.02068
Verhagen, A. M. et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43–53 (2000).
pubmed: 10929712 doi: 10.1016/S0092-8674(00)00009-X pmcid: 10929712
Verhagen, A. M. et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277, 445–454 (2002).
pubmed: 11604410 doi: 10.1074/jbc.M109891200 pmcid: 11604410
Vasudevan, D. & Ryoo, H. D. Regulation of Cell Death by IAPs and Their Antagonists. Curr Top Dev Biol 114, 185–208 (2015).
pubmed: 26431568 pmcid: 4861076 doi: 10.1016/bs.ctdb.2015.07.026
Schimmer, A. D. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64, 7183–7190 (2004).
pubmed: 15492230 doi: 10.1158/0008-5472.CAN-04-1918 pmcid: 15492230

Auteurs

Amanda Torrentes-Carvalho (A)

Departamento de Imunobiologia, Instituto de Biologia -Universidade Federal Fluminense (UFF), Niterói, Brazil.

Juan Camilo Sánchez-Arcila (JC)

Laboratório de Imunologia Viral, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

Tamiris Azamor (T)

Laboratório de Tecnologia Imunológica - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

Luciana Santos Barbosa (LS)

Laboratório de Imunologia Viral, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

Eugênio Damaceno Hottz (ED)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

Mariana Gandini (M)

Laboratório de Microbiologia Celular, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

Fernando Augusto Bozza (FA)

Laboratório de Medicina Intensiva, Intituto Nacional de Infectologia Evandro Chagas-INI, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

Rivaldo Venâncio da Cunha (RV)

Universidade Federal do Mato Grosso do Sul (UFMS), Faculdade de Medicina, Campo Grande, Mato Grosso do Sul, Brazil.

Luzia Maria de Oliveira Pinto (LM)

Laboratório de Imunologia Viral, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.

Paulo Vieira Damasco (PV)

Hospital Universitário Gafreé & Guinle, Universidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil; Hospital Pedro Ernesto, Universidade Estadual do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.

Elzinandes Leal de Azeredo (EL)

Laboratório de Imunologia Viral, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil. elzinandes@ioc.fiocruz.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH